Funktionen:
Professor für VWL und quantitative Methoden
Mitglied Senatsausschuss Forschung & Transfer
Hochschulbeauftragter für Studierende mit chronischen Erkrankungen und körperlichen Beeinträchtigungen am Campus Schwäbisch Hall
Forschungsschwerpunkte:
- Marketingforschung
- Statistische Methoden der BWL
- Gesundheitsökonomie
Veröffentlichungen (Auswahl):
- M.
Schlander, M.A. Khan, A. Iezzi, A. Maxwell, O. Schwarz, J. Richardson:
The Measurement of health-related Quality of Life: German Findings from
the Multi-Instrument Comparison (MIC) Study. Value in Health 16 [7]
(2013) A330.
- M. Schlander, O.
Schwarz, G.-E. Trott, T. Banaschewski: Attention-Deficit Hyperactivity
Disorder (ADHD), 2003-2009: A Longitudinal Analysis of Prevalence,
Health Care and Direct Cost Based upon Administrative Data from
Nordbaden / Germany. Symposium. European Child + Adolescent Psychiatry
22 [Suppl. 2] (2013) S102 (Abstract No. S2-06-05).
- O.
Schwarz, M. Schlander: Mental Health Care Research in Germany:
Sociodemographic Characteristics of the Nordbaden Database. European
Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S100 (Abstract No.
S2-06-01).
- G.-E. Trott, O.
Schwarz, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer, M.
Schlander: The Rising Administrative Prevalence of Attention-Deficit
Hyperactivity Disorder (ADHD) in Nordbaden /Germany and Specialist
Involvement in Health Care Provision. European Child + Adolescent
Psychiatry 22 [Suppl. 2] (2013) S101-102 (Abstract No. S2-06-04).
- T.
Banaschewski, O. Schwarz, G.-E. Trott, W. Scheller, M. Viapiano, N.
Bonauer, M. Schlander: The Evolving Treatment Patterns for
Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden /Germany: A
Retrospective Study Based upon Administrative Data, Years 2003-2009.
European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S101
(Abstract No. S2-06-03).
- M.
Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski, W. Scheller, M.
Viapiano, N. Bonauer: The Medical Cost Attributable to Attention-Deficit
Hyperactivity Disorder (ADHD) in Nordbaden / Germany: A Study From a
Health Care Payer’s Perspective Based on Claims Data. European Child +
Adolescent Psychiatry 22 [Suppl. 2] (2013) S100-101 (Abstract No.
S2-06-02).
- M. Schlander, G.E.
Trott, T. Banaschewski, O. Schwarz: New Estimates of the Direct Medical
Cost of Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany.
Value in Health Vol. 16 Issue 7 (2013), Page A546
- M.
Schlander, T. Banaschewski, G.E. Trott, O. Schwarz: Medication
Treatment and Health Care Utilization for
Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany. Value in
Health Vol. 16, Issue 7 (2013), Page A340
- M.
Schlander, O. Schwarz: Health Care Utilization Research in Germany:
Characterization of the Nordbaden Database. 15th Annual European
Congress of the International Society for Pharmacoeconomics &
Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value
in Health 15 [7] (2012) A303
- M.
Schlander,O. Schwarz, G.-E. Trott, T. Banaschewski, W. Scheller, M.
Viapiano, N. Bonauer: Most Frequently Diagnosed Mental Health Problems
in a German Population. 15th Annual European Congress of the
International Society for Pharmacoeconomics & Outcomes Research
(ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7]
(2012) A344.
- M. Schlander, O.
Schwarz, T. Banaschewski, G.-E. Trott, M. Viapiano, N. Bonauer, W.
Scheller: Involvement of CNC Specialists in Health Care Provision for
Patients with Attention-Deficit / Hyperactivity Disorder (ADHD): New
Data from Nordbaden, Germany, 2003 – 2009. 15th Annual European Congress
of the International Society for Pharmacoeconomics & Outcomes
Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in
Health 15 [7] (2012) A535.
- M.
Schlander, O. Schwarz, A. Rothenberger, V. Roessner: Tic disorders:
prevalence and co-occurrence with attention-deficit/hyperactivity
disorder in a German community sample. European Psychiatry, 2011, Volume
26, Issue 6, S. 370 - 374.
- M.
Schlander, O. Schwarz, G,-E. Trott, T. Banaschewski, M. Viapiano, N.
Bonauer: Increasing Use of Medication for Treatment of Attention Deficit
hyperactivity Disorder (ADHD) in Germany between 2003 and 2009. 14th
Annual European Congress of the International Society for
Pharmacoeconomics & Outcomes Research (ISPOR), Madrid / Spain,
November 05-08, 2011. Value in Health 14 [7] (2011) A300.
- M.
Schlander, A. Philipsen, O. Schwarz, and the COMPAS Study Group: The
Cost Effectiveness of Clinically Proven Treatment Strategies for ADHD in
Adult Patients. 14th Annual European Congress of the International
Society for Pharmacoeconomics & Outcomes Research (ISPOR), Madrid /
Spain, November 05-08, 2011. Value in Health 14 [7] (2011) A403.
- M.
Schlander, G.-E. Trott, O. Schwarz: Gesundheitsökonomie der
Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) in Deutschland –
Teil 1: Versorgungsepidemiologie und Krankheitskosten. Der Nervenarzt,
2010, Volume 81 (3), S. 289 - 300.
- M.
Schlander, G.-E. Trott, O. Schwarz: Gesundheitsökonomie der
Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) in Deutschland –
Teil 2: Therapeutische Optionen und ihre Kosteneffektivität. Der
Nervenarzt, 2010, Volume 81 (3), S. 301 - 314.
- O.
Schwarz: Absicherung des Net Promoter Score - die Ermittlung von
Konfidenzintervallen mit dem Bootstrap Verfahren. Der Markt – Journal
für Marketing, 48 (3), 2009, S. 105 - 115.
- M.
Schlander, O. Schwarz, G.-E. Trott, M. Viapiano, N. Bonauer: Who Cares
for Patients with Attention-Deficit/Hyperactivity Disorder? Insights
from Nordbaden (Germany). European Child & Adolescent Psychiatry, 16
(7), 2007, S. 430 - 438.
- M.
Schlander, O. Schwarz: Finanzierbarkeit steigender Gesundheitsausgaben
in Deutschland: eine makroökonomische Betrachtung. Gesundheitsökonomie
& Qualitätsmanagement 10, 2005, S. 178 - 187.
- O.
Schwarz: Kundenanalysen zur Erhöhung von Responseraten im Database
Marketing; in: Studium Duale - Jahrbuch der Berufsakademie Mannheim
2005.